A comprehensive review published in Gut and Liver provides an updated overview of quality standards and technical decision-making for endoscopic retrograde cholangiopancreatography (ERCP)-guided biliary stenting. Despite major technological advances, ERCP remains one of the most technically demanding gastrointestinal procedures because of the persistent risks of post-ERCP pancreatitis, bleeding, perforation, cholangitis, and stent-related complications.
The review emphasizes that successful ERCP depends not only on technical expertise but also on adherence to established quality indicators, including appropriate patient selection, successful biliary cannulation, complete biliary drainage, complication monitoring, and continuous outcome auditing.
Key Highlights
The authors provide practical guidance on selecting:
- Plastic biliary stents.
- Self-expandable metal stents (SEMS).
- Covered and uncovered metal stents.
Recommendations are discussed across multiple clinical scenarios, including:
- Benign biliary strictures.
- Malignant biliary obstruction.
- Acute cholangitis.
- Preoperative biliary decompression.
- Palliative biliary drainage.
Clinical Relevance
For laparoscopic, HPB, and biliary surgeons, understanding ERCP quality standards is essential for multidisciplinary management of choledocholithiasis, gallbladder cancer, obstructive jaundice, perioperative bile duct injuries, and cholangitis. Appropriate stent selection and timely biliary drainage directly influence surgical planning, operative timing, postoperative outcomes, and coordination with advanced endoscopy teams.
Source: PubMed Study
Machine Learning Risk Model May Personalize Adjuvant Chemotherapy After Gallbladder Cancer Surgery
A real-world study published in Gut and Liver evaluated the role of machine learning in predicting early recurrence following surgery for Stage II or higher gallbladder cancer. The analysis included 395 patients treated surgically between 2005 and 2022.
Investigators developed a machine learning-based recurrence prediction model that stratified patients into low- and high-risk groups to determine which patients were most likely to benefit from postoperative chemotherapy.
Key Findings
Among patients classified as low risk:
- Adjuvant chemotherapy did not significantly improve 5-year overall survival compared with surveillance.
Among high-risk patients:
- Five-year overall survival improved from 37.8% to 52.1% with adjuvant chemotherapy.
These findings suggest that individualized recurrence-risk prediction may help avoid unnecessary chemotherapy in low-risk patients while identifying those most likely to benefit from additional treatment.
Clinical Relevance
Gallbladder cancer is frequently diagnosed unexpectedly after laparoscopic cholecystectomy or during hepatopancreatobiliary surgery. Accurate pathological staging, adequate lymph node assessment, R0 resection, and early multidisciplinary referral remain critical. Machine learning-based risk prediction may soon assist surgeons and oncologists in developing more personalized postoperative treatment strategies.
Source: PubMed Study
Extent-Based Endoscopic Assessment May Improve Ulcerative Colitis Evaluation in the AI Era
A scoping review published in Gut and Liver examined emerging endoscopic scoring systems for ulcerative colitis that incorporate not only the severity of inflammation but also its overall anatomical extent throughout the colon.
Traditional scoring systems often focus on the single worst inflamed segment, whereas newer extent-based indices provide a more comprehensive assessment of total inflammatory burden.
Key Findings
Across 21 published studies, extent-integrated scoring systems demonstrated:
- Better correlation with inflammatory biomarkers.
- Improved agreement with histopathological findings.
- More comprehensive disease burden assessment.
Artificial intelligence-assisted colonoscopy systems also showed encouraging early performance by automatically mapping inflammatory distribution and improving scoring reproducibility. However, external validation remains limited, and prediction of long-term relapse was inconsistent.
Clinical Relevance
For colorectal surgeons managing ulcerative colitis, accurate assessment of total inflammatory burden is increasingly important when considering restorative proctocolectomy, dysplasia surveillance, timing of surgery, and postoperative pouch management. Future AI-assisted colonoscopy may provide more objective disease mapping and support multidisciplinary decision-making before operative intervention.
Source: PubMed Study
Key Takeaway
Today's evidence highlights the growing integration of precision medicine, artificial intelligence, and multidisciplinary decision-making in gastrointestinal surgery. Updated ERCP quality standards emphasize evidence-based biliary drainage, machine learning is beginning to personalize adjuvant treatment after gallbladder cancer, and extent-based AI-supported endoscopic assessment promises more accurate evaluation of ulcerative colitis. Together, these advances move minimally invasive surgery toward increasingly individualized, data-driven, and patient-centered care.